Thomasclavelia ramosais a Signature of Gut Dysbiosis associated with Alcohol-Related Hepatocellular Carcinoma: A First Microbial Culturomics Study DOI Creative Commons

Reham Magdy Wasfy,

Anissa Abdoulaye,

Patrick Borentain

et al.

medRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown

Published: Aug. 20, 2024

Abstract Background Gut microbiota alteration is implicated in the pathogenesis of alcoholic liver disease (ALD) and HCC. No study has characterized dysbiosis associated with ALD by microbial culturomics, an approach that certifies viability allows characterization pathobiont strain candidates. Methods A case-control was conducted on patients without HCC (ALD-NoHCC) (n=16), (ALD-HCC) (n=19), controls (n=24). 16S rRNA amplicon sequencing culturomics were used as complementary methods for gut microbiome profiling. Results By Thomasclavelia ramosa most enriched detected all samples (100%), while it cultivated only a small proportion (20%, p < 0.001). 3-groups linear discriminant analysis, T. increased explicitly ALD-HCC group (LDA-score > 5, 0.05). Conclusions ramosa, identified 16 sequencing, ALD-HCC. Alongside recently reported vitro genotoxicity this species colorectal cancer, been candidate oncobiont Highlights The signature explored cultured from included patients, but 20% (p significantly alcohol-related sequencing. putative ALD-HCC, thus opening new avenues diagnosis treatment. Graphical abstract

Language: Английский

Thomasclavelia ramosa and alcohol-related hepatocellular carcinoma: a microbial culturomics study DOI Creative Commons

Reham Magdy Wasfy,

Anissa Abdoulaye,

Patrick BORENTAIN

et al.

Gut Pathogens, Journal Year: 2025, Volume and Issue: 17(1)

Published: May 7, 2025

Gut microbiota alteration is implicated in the pathogenesis of alcoholic liver disease (ALD) and associated hepatocellular carcinoma (HCC). No study has characterized dysbiosis with ALD by microbial culturomics, which certifies viability allows pathobiont strain candidates to be characterized. A case-control (n = 59) was conducted on patients without HCC (ALD-NoHCC, n 16), (ALD-HCC, 19) controls 24) groups. 16 S rRNA amplicon sequencing culturomics were used as complementary methods for gut microbiome profiling. Compared control group, Thomasclavelia ramosa Gemmiger formicilis significantly increased ALD-HCC group Mediterraneibacter gnavus ALD-NoHCC using sequencing. By T. detected all samples (100%), most enriched since cultivated only a small proportion (20%, p < 0.001). ramosa, identified sequencing, may ALD-HCC. These results highlight potential role cancer, line its genotoxic properties tumor growth-promoting effect gnotobiotic mice recently reported.

Language: Английский

Citations

0

Role of the Gut Microbiome in Metabolic dysfunction-Associated Steatotic Liver Disease DOI
Salim Maher,

Jayashi Rajapakse,

Emad El‐Omar

et al.

Seminars in Liver Disease, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 10, 2024

The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD)—previously described as nonalcoholic fatty disease—continues to rise globally. Despite this, therapeutic measures for MASLD remain limited. Recently, there has been a growing interest in the gut microbiome's role pathogenesis MASLD. Understanding this relationship may allow administration therapeutics that target microbiome and/or its function alleviate development or progression. This review will discuss interplay between structure and relation MASLD, assess diagnostic yield microbiome-based signatures noninvasive tool identify severity, examine current emerging therapies targeting microbiome–liver axis.

Language: Английский

Citations

2

Prevention and control of risk factors in metabolic and alcohol-associated steatotic liver disease DOI Open Access

Hailemichael Desalegn,

R.H.A. Farias, D.G. Hudson

et al.

Metabolism and Target Organ Damage, Journal Year: 2024, Volume and Issue: 4(3)

Published: July 29, 2024

Steatotic liver disease (SLD), including metabolic dysfunction-associated steatotic (MASLD) and alcohol-associated (ALD), is the primary cause of illness mortality. In particular, MASLD affects more than 30% global population, while ALD accounts for 5.1% all diseases injuries worldwide. The SLD spectrum includes a variety clinical conditions, from mild fatty inflammation to different stages fibrosis. Additionally, both conditions (MASLD ALD) can be complicated by hepatocellular carcinoma (HCC), around one-third patients also develop at least one alcohol‐associated hepatitis (AH) episode. Both these are associated with multiple extrahepatic complications, such as cardiovascular disease, chronic kidney malignancies. MASLD, rapid rise in obesity type 2 diabetes mellitus (T2DM) prevalence due Westernized lifestyles has led an increase MASLD. Thus, prevention control cardiometabolic risk factors (CMRFs) cornerstone its treatment. Hypertension atherogenic dyslipidemia important CMRFs Susceptible individuals adversely affected even small amount alcohol consumption (though there no agreed definition amount), increasing severe outcomes faster progression disease. This review explores that play role development SLD, especially focusing on management levels use prevent progression.

Language: Английский

Citations

1

Is there a role for intestinal sporobiota in the antimicrobial resistance crisis? DOI Creative Commons
A. Romero, Beatriz Ruiz‐Villafán, Sergio Sánchez

et al.

Microbiological Research, Journal Year: 2024, Volume and Issue: 288, P. 127870 - 127870

Published: Aug. 10, 2024

Antimicrobial resistance (AMR) is a complex issue requiring specific, multi-sectoral measures to slow its spread. When people are exposed antimicrobial agents, it can cause resistant bacteria increase. This means that the use, misuse, and excessive use of agents exert selective pressure on bacteria, which lead development "silent" reservoirs genes. These genes later be mobilized into pathogenic contribute spread AMR. Many socioeconomic environmental factors influence transmission dissemination genes, such as quality healthcare systems, water sanitation, hygiene infrastructure, pollution. The sporobiota an essential part gut microbiota plays role in maintaining homeostasis. However, because spores highly transmissible easily, they vector for resistome, particularly mobile important tracking, managing, limiting among commensal bacterial species.

Language: Английский

Citations

0

Ruminococcus gnavus in the gut: driver, contributor, or innocent bystander in steatotic liver disease? DOI Creative Commons
Vik Meadows, Jayson M. Antonio, Ronaldo P. Ferraris

et al.

FEBS Journal, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 26, 2024

The human gut microbiome plays a crucial role in regulating intestinal and systemic health, impacting host immune response metabolic function. Dysbiosis of the is linked to various diseases, including steatotic liver diseases. Metabolic dysfunction‐associated disease (MASLD), chronic characterized by excess hepatic lipid content impaired metabolism, leading cause worldwide. Among microbes, Ruminococcus gnavus ( R. ) has garnered attention for its association with inflammatory While abundance correlates fat accumulation, further research needed identify causal or therapeutic intervention disease. This review surveys our current understanding development progression highlighting potential mechanisms through metabolite secretion, emphasizes need comprehensive analyses longitudinal studies better understand gnavus' impact on health. knowledge could pave way targeted interventions aimed at modulating microbiota treat prevent MASLD comorbidities.

Language: Английский

Citations

0

Thomasclavelia ramosais a Signature of Gut Dysbiosis associated with Alcohol-Related Hepatocellular Carcinoma: A First Microbial Culturomics Study DOI Creative Commons

Reham Magdy Wasfy,

Anissa Abdoulaye,

Patrick Borentain

et al.

medRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown

Published: Aug. 20, 2024

Abstract Background Gut microbiota alteration is implicated in the pathogenesis of alcoholic liver disease (ALD) and HCC. No study has characterized dysbiosis associated with ALD by microbial culturomics, an approach that certifies viability allows characterization pathobiont strain candidates. Methods A case-control was conducted on patients without HCC (ALD-NoHCC) (n=16), (ALD-HCC) (n=19), controls (n=24). 16S rRNA amplicon sequencing culturomics were used as complementary methods for gut microbiome profiling. Results By Thomasclavelia ramosa most enriched detected all samples (100%), while it cultivated only a small proportion (20%, p < 0.001). 3-groups linear discriminant analysis, T. increased explicitly ALD-HCC group (LDA-score > 5, 0.05). Conclusions ramosa, identified 16 sequencing, ALD-HCC. Alongside recently reported vitro genotoxicity this species colorectal cancer, been candidate oncobiont Highlights The signature explored cultured from included patients, but 20% (p significantly alcohol-related sequencing. putative ALD-HCC, thus opening new avenues diagnosis treatment. Graphical abstract

Language: Английский

Citations

0